US wants ingredient in swine flu vaccine by May

Apr 28, 2009 By LAURAN NEERGAARD , AP Medical Writer

(AP) -- U.S. scientists hope to have a key ingredient for a swine flu vaccine ready in early May, but tell The Associated Press that the novel virus grows slowly in eggs - the chief way flu vaccines are made.

Even if all goes well, it still will take months before any shots are available for the necessary safety testing in volunteers.

Dr. Jesse Goodman, the Food and Drug Administration's swine flu chief, said Tuesday that scientists are working, in his words, "at 100 miles an hour" to create good raw material to deliver to manufacturers.

The researchers must engineer a strain that could trigger the without causing illness. At the Centers for Disease Control and Prevention, chief Dr. Ruben Donis says that work is about a third completed.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Experts favor US approval of Merck sleeping pill (Update)

add to favorites email to friend print save as pdf

Related Stories

Swine flu cases up to 7, probe expanding

Apr 23, 2009

(AP) -- Health officials say a unique type of swine flu has now been diagnosed in seven people in California and Texas, up from the two reported earlier this week. The five new cases in the two states have all recovered, ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Bird flu vaccine not effective in trial

Feb 17, 2006

A highly anticipated bird flu vaccine trial in Australia has proven protective for only a small minority of the 400 volunteers in the clinical trial.

CDC: Mild flu season apparently winding down

Apr 07, 2009

(AP) -- The flu season is winding down and turning out to be one of the mildest in years, according to data from the U.S. Centers for Disease Control and Prevention.

Recommended for you

Glaxo, US partnering to develop new antibiotics

16 hours ago

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

New sleeping pill poised to hit US markets

May 21, 2013

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Global recommendations on child medicine

May 21, 2013

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...

User comments : 0

More news stories

Fast-acting mothers' milk for healthier babies

Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.

Weird science: Crystals melt when they're cooled

(Phys.org) —Growing thin films out of nanoparticles in ordered, crystalline sheets, to make anything from microelectronic components to solar cells, would be a boon for materials researchers, but the physics ...

Unlocking secrets of cell reproduction

Research published in Open Biology today identifies, for the first time, nearly all the genes required for reproduction of a cell in a living organism.

Wildlife losses now stabilising

Efforts to conserve biodiversity in the UK, Belgium and Netherlands may be working, despite the widespread perception that wildlife is in terminal decline, a new study suggests.